Pharmalive -- June 24-- A targeted therapy that has generated excitement for its early success in breast cancer is now being tested in the Triangle on other cancers, including often-deadly ovarian tumors.
Pharmalive -- June 24-- A targeted therapy that has generated excitement for its early success in breast cancer is now being tested in the Triangle on other cancers, including often-deadly ovarian tumors.
